The Hype Problem
Regenerative neurotherapies occupy a strange space in medicine. The underlying biology is legitimate. The clinical evidence is growing. Yet the marketing is often absurd.
Stem cell clinics claim they'll rebuild your brain and restore your lost neurons. NAD+ is packaged as a fountain of youth. Exosomes are described as miracle particles. This hype creates a backlash where mainstream medicine dismisses regenerative therapies entirely, even when the evidence supports their use.
The truth is messier than either narrative. These therapies engage real biology, produce measurable changes, and can improve outcomes. But not because they're magic. Because they address specific mechanisms of dysfunction in ways that conventional medicine doesn't.
The Stem Cell Myth: Becoming New Neurons
The most persistent myth: stem cells migrate to your brain and differentiate into new neurons that restore lost function.
This is false. And it's been false for decades. Yet it persists in clinic marketing materials.
Mesenchymal stem cells (MSCs)—the cells used in most clinical applications—do not become neurons under physiological conditions. They don't migrate effectively across the blood-brain barrier. They don't integrate into neural circuits. What they actually do is paracrine signaling: they secrete bioactive molecules that change the environment where they're injected.
Those molecules include:
- Anti-inflammatory cytokines (IL-10, TGF-β) that suppress microglia activation and reduce neuroinflammation.
- Trophic factors (NGF, BDNF, GDNF) that support neuronal survival and plasticity.
- Exosomes containing bioactive cargo (microRNAs, proteins) that modulate immune function and cellular repair.
- Metabolic modulators that enhance mitochondrial function and energy production.
When this environment changes, the brain's own circuits work better. Not because new neurons were added, but because existing neurons have less inflammation, better metabolic support, and reduced glial reactivity. This is a meaningful change. It's not the sci-fi narrative clinics advertise, but it's real neurobiology.
The evidence is strongest for post-concussion syndrome and chronic pain syndromes, where neuroinflammation is a major driver of dysfunction. When you reduce that inflammation, function improves. Cognitive improvements are typically modest—perhaps 20-30% improvement in specific domains—not dramatic reversal of cognitive decline. That's important to know upfront.
The NAD+ Reality: Substrate, Not Cure
NAD+ is a critical coenzyme. Sirtuins (SIRT1-7) use it as substrate for enzymatic activity. Sirtuins regulate mitochondrial biogenesis, DNA repair, inflammation, and metabolic signaling. NAD+ levels decline with age. In principle, replenishing NAD+ should upregulate sirtuin activity and engage anti-aging pathways.
In practice, it's more complicated.
IV NAD+ can increase circulating NAD+ and activate sirtuins transiently. But NAD+ itself doesn't cross the blood-brain barrier efficiently. Much of the benefit for brain function likely comes from peripheral NAD+ replenishment activating systemic metabolic pathways (mitochondrial biogenesis in muscle, liver, adipose tissue) that secondarily support brain health. Or from direct hepatic effects that improve glucose tolerance and reduce inflammation.
Does NAD+ IV improve cognitive function in everyone? No. Does it work as an anti-aging intervention in people who are already exercising, sleeping well, and managing metabolic health? Marginally. Its real value is as part of a larger metabolic protocol, particularly in people with documented metabolic dysfunction (insulin resistance, impaired glucose tolerance, mitochondrial disease).
The dose matters too. Wellness clinics often use 1-2g of NAD+ IV, which is enough to produce subjective energy improvement but probably not enough to substantially shift sirtuin activity. Research-grade protocols often use 5-10g, which is a different intervention entirely.
Exosomes: What We Know and Don't Know
Exosomes are tiny extracellular vesicles (30-200 nanometers) secreted by cells. They carry microRNAs, proteins, and lipids that can be transferred to recipient cells and alter their function. In theory, exosomes could be bioactive vehicles for cellular signaling without the cells themselves needing to survive.
The evidence is real but preliminary. Exosomes from mesenchymal stem cells show anti-inflammatory effects and support neuronal survival in in vitro and animal models. Early human studies show some clinical benefit in ischemic stroke and traumatic brain injury. But the field is young. We don't know the optimal source tissue, concentration, dosing, or route of administration. We don't know which specific exosome subpopulations are responsible for clinical effects.
The marketing is ahead of the evidence. Clinics selling exosomes as cancer treatment, neurodegeneration cure, or anti-aging miracle are overselling. Exosomes are probably beneficial for neuroinflammatory conditions, but calling them "cell-free stem cells" is marketing language designed to avoid FDA oversight, not an accurate description.
At NGP, if we use exosomes, it's in the context of careful patient selection and realistic expectations. We know roughly what they do (reduce inflammation, support trophic signaling). We're less sure about optimal dosing and long-term outcomes. Honesty about that uncertainty is required.
Evaluating Claims Critically
If you encounter marketing for a regenerative therapy, ask these questions:
What's the mechanism? If the clinic claims stem cells will "become new neurons," that's false. If they claim stem cells secrete anti-inflammatory factors that reduce neuroinflammation, that's consistent with biology. If they claim NAD+ will instantly reverse aging, that's hype. If they claim NAD+ can support mitochondrial function when combined with exercise and metabolic optimization, that's plausible.
What's the evidence? Are they citing peer-reviewed research or just testimonials? Are they funding the research themselves (which creates bias)? Are they comparing outcomes to control groups or just showing before-and-after narratives? Large, controlled trials >> small unblinded studies >> testimonials and anecdotes.
What are realistic outcomes? Any clinic claiming 80-90% cure rates for cognitive decline is lying. Realistic outcomes for regenerative therapies in brain disease are modest: 15-30% improvement in specific function, sometimes more, sometimes nothing. If that's not honestly stated upfront, the clinic is prioritizing marketing over medicine.
Is this being used as replacement for other necessary interventions? If someone suggests stem cells as an alternative to sleep optimization and metabolic treatment, they don't understand neurobiology. Regenerative therapies should be integrated with, not substituted for, foundational health practices.
What's the cost? If a clinic charges $30,000 for an IV therapy with modest evidence of benefit, that's profit-driven. If they charge $5,000 for a comprehensive assessment, sleep optimization, metabolic protocol, and regenerative support, that's differently priced and differently justified.
The Evidence-Based Approach
At NGP, we use regenerative therapies within an evidence-based framework. This means:
- Clear patient selection: These therapies are used in patients with documented neurobiological dysfunction (elevated neuroinflammation, mitochondrial dysfunction, white matter disruption) who've plateaued on conventional treatment.
- Realistic outcome expectations: We discuss likely improvements (15-30% in specific domains), timeline (3-6 months to see benefit), and need for concurrent lifestyle intervention.
- Objective assessment: We measure outcomes with neuropsychological testing, biomarkers, and advanced imaging before and after intervention.
- Integration with fundamentals: No therapy is used in isolation. Sleep, metabolic health, and psychological integration are optimized first and maintained throughout.
- Acknowledgment of uncertainty: For exosomes and other newer therapies, we're honest about what we know, what we're still learning, and what remains unclear.
This approach is less dramatic than "stem cell therapy cures Alzheimer's" but more honest and more likely to produce sustained improvement. The goal isn't miracle recovery. It's engaging the brain's intrinsic capacity for repair and optimization when the fundamentals are solid and the biochemical environment is supportive.
That's a more powerful narrative than marketing hype. A person who improves because they sleep deeply, metabolize glucose efficiently, process trauma, and have reduced neuroinflammation has a brain that will sustain that improvement. A person who gets one therapy and expects reversal is likely to regress when the therapy wears off and the underlying dysfunction hasn't been addressed.